Overview
Sergio Garcia-Crespo practices in Montreal, Canada. Mr. Garcia-Crespo is rated as an Advanced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Cerebral Hypoxia, and Diabetic Retinopathy.
His clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Age-Related Macular Degeneration (ARMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)Mr. Garcia-Crespo isAdvanced. Learn about Age-Related Macular Degeneration (ARMD).
- Cerebral HypoxiaMr. Garcia-Crespo isAdvanced. Learn about Cerebral Hypoxia.
- Diabetic RetinopathyMr. Garcia-Crespo isAdvanced. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationMr. Garcia-Crespo isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Experienced
- Carotid Artery DiseaseMr. Garcia-Crespo isExperienced. Learn about Carotid Artery Disease.
- Diabetic Macular Edema (DME)Mr. Garcia-Crespo isExperienced. Learn about Diabetic Macular Edema (DME).
- NeuroretinitisMr. Garcia-Crespo isExperienced. Learn about Neuroretinitis.
- ObesityMr. Garcia-Crespo isExperienced. Learn about Obesity.